ABEV vs KR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ABEV's deterministic health score is weak with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock trades above the Graham Number of $2.24 at a current price of $2.78, suggesting modest overvaluation for a defensive stock, though below the growth-based intrinsic value of $5.9. Strong profitability metrics like a 17.73% profit margin and 26.01% operating margin are offset by declining revenue growth of -5.70% YoY and a concerning 104.3% dividend payout ratio. Analysts rate it a 'hold' with a $2.93 target, implying limited upside.
The Kroger Co. presents a dichotomy between strong operational execution and deteriorating financial health. While the company maintains a stellar earnings beat record and strong YoY earnings growth (50.9%), its deterministic health is only 'Stable' with a Piotroski F-Score of 4/9. Valuation is a primary concern, as the current price of $66.93 significantly exceeds both the Graham Number ($17.90) and the growth-based Intrinsic Value ($45.43). High leverage (Debt/Equity 4.16) and poor liquidity (Current Ratio 0.80) offset the bullish analyst sentiment.
Compare Another Pair
Related Comparisons
ABEV vs KR: Head-to-Head Comparison
This page compares Ambev S.A. (ABEV) and The Kroger Co. (KR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.